Logo Image
News
All NewsDosing & Delivery InnovationsPress ReleasesProduct Approvals and Launches
Video
All Video TypesAJMC TVGuidelinesInsightsOnLocationPayer PerspectivesPeer ExchangePost Conference PerspectivesShortsStakeholder Summit
Podcasts
Journals
All JournalsThe American Journal of Managed CarePopulation Health, Equity & OutcomesEvidence-Based OncologyAbout Supplements and Featured PublicationsSupplements and Featured Publications IssuesSubmit a Manuscript
More
Conferences
Conference CoverageConference ListingPost Conference Perspectives
Events
AJMC EventsEvents CalendarInstitute for Value-Based MedicinePatient-Centered Oncology CarePopulation Health RoundtablesWebinars
Resources
Interactive ToolsFormulary CentralClinical SpotlightMicrositesSponsored Content
CE
About AJMC
AJMC StaffAnniversarySeema Sonnad AwardStrategic Alliance Partners

Subscribe

  • News
  • Video
  • Podcasts
  • Journals
  • Conferences
  • Events
  • Resources
  • CE
  • About AJMC
  • Subscribe
  • Biosimilars
  • Cardiorenalmetabolic
    • Cardiomyopathy
    • Cardiovascular
    • Chronic Kidney Disease
    • Diabetes
    • Heart Failure
    • Type 1 Diabetes
  • Dermatology
    • Alopecia
    • Atopic Dermatitis
    • Chronic Hand Eczema
    • Psoriasis
  • Gastroenterology
  • Hematology
    • ALL/AML
    • CLL/SLL
    • GVHD
    • Hemophilia
    • Mantle Cell Lymphoma
    • Multiple Myeloma
    • Myelodysplastic Syndromes
    • Myeloproliferative Neoplasms
    • Non-Hodgkin Lymphoma
    • Rare Blood
  • Hepatology
    • Hepatitis
    • Liver
    • MASH
  • Immunology
    • Allergy
    • Autoimmune
    • Inflammation
    • Lupus
    • Myasthenia Gravis
    • Rheumatoid Arthritis
  • Infectious Disease
    • COVID-19
    • HIV
    • RSV
    • Vaccines
  • Mental Health
    • Major Depressive Disorder
    • Sleep
  • Neurology
    • Duchenne Muscular Dystrophy
    • Epilepsy
    • Multiple Sclerosis
    • Parkinson Disease
  • Obesity
  • Oncology
    • Breast Cancer
    • Cholangiocarcinoma
    • Colorectal Cancer
    • Immuno-Oncology
    • Liver Cancer
    • Non–Small Cell Lung Cancer
    • Ovarian Cancer
    • Prostate Cancer
    • Skin Cancer
    • Small Cell Lung Cancer
    • Soft Tissue Sarcoma
  • Ophthalmology
  • Pulmonology
    • COPD
    • Pulmonary Arterial Hypertension
  • Rare Disease
    • Spinal Muscular Atrophy
  • Respiratory
    • Asthma
    • Pulmonary Fibrosis
  • Rheumatology
  • Urology
    • Overactive Bladder
  • Women's Health
    • Endometriosis
  • Biosimilars
  • Bispecifics Network
  • Center on Health Equity & Access
  • Digital Health
  • Dosing & Delivery Innovations
  • Formulary
  • Gene Therapy
  • Guidelines
  • Health Care Administration
    • Employers
    • Medicare
    • Reimbursement
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Population Health
  • Product Approvals and Launches
  • Technology
  • Value-Based Care
Spotlight -
Free In-Person Regional Events Focused on Oncology and Population Health
Advertisement

Louise M. Dube, PhD

Advertisement

Articles by Louise M. Dube, PhD

Safety and Clinical Efficacy of Zileuton in Patients with Chronic Asthma

ByStephen C. Lazarus, MD,Theodore Lee, MD,James P. Kemp, MD,Sally Wenzel, MD,Louise M. Dube, PhD,Rachel F. Ochs, MD, JD,Pierre J. Carpentier, MD,James F. Lancaster, PhD,the Zileuton Study Group
June 1st 1998

Randomized Trial of Zileuton in Patients with Moderate Asthma: Effect of Reduced Dosing Frequency and Amounts on Pulmonary Function and Asthma Symptoms

ByLawrence M. DuBuske, MD,Jay Grossman, MD,Louise M. Dube, PhD,Linda J. Swanson, PhD,James F. Lancaster, PhD,the Zileuton Study Group
April 1st 1997
Advertisement

Latest Updated Articles

  • Safety and Clinical Efficacy of Zileuton in Patients with Chronic Asthma
    Safety and Clinical Efficacy of Zileuton in Patients with Chronic Asthma

    June 1st 1998

  • Randomized Trial of Zileuton in Patients with Moderate Asthma:  Effect of Reduced Dosing Frequency and Amounts on Pulmonary Function and Asthma Symptoms
    Randomized Trial of Zileuton in Patients with Moderate Asthma: Effect of Reduced Dosing Frequency and Amounts on Pulmonary Function and Asthma Symptoms

    April 1st 1997



Advertisement
Advertisement

Trending on AJMC

1

Survodutide Phase 3 Data Signal Metabolic Gains Beyond Weight Loss

2

Measles Cases Climb to 2000 in the US, Increasing Cases Year Over Year

3

GLP-1 Drugs Tackle Both Skin Inflammation and Metabolism in Psoriasis

4

Oral Orforglipron Added to Basal Insulin Cuts HbA1c in Type 2 Diabetes

5

Emerging Data Suggest Survodutide Targets Liver Fat More Rapidly Than Weight Loss: Lee Kaplan, MD, PhD

Brand Logo
  • About
  • Contact
  • Editorial Boards
  • Advertise
  • Do Not Sell My Information
  • Terms & Conditions
  • Privacy Policy

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

© 2026 MJH Life Sciences®

All rights reserved.

Secondary Brand Logo
Alt TextAlt Text